XML 28 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net increase (decrease) in net assets resulting from operations $ 611,951 $ 404,556 $ 460,422
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Net change in unrealized (appreciation) depreciation on investments 50,841 126,493 (104,727)
Net change in unrealized (appreciation) depreciation on translation of assets and liabilities in foreign currencies 3,732 (4,344) 549
Net realized (gain) loss on investments 6,205 (37,402) (7,785)
Net accretion of discount and amortization of premium (52,865) (47,429) (62,799)
Payment-in-kind interest capitalized (51,558) (40,324) (9,152)
Amortization of deferred financing costs 5,471 4,008 2,676
Amortization of original issue discount and debt issuance costs 9,336 10,405 7,102
Purchases of investments (1,483,303) (961,768) (6,824,327)
Proceeds from sale of investments and principal repayments 1,305,234 1,174,176 2,734,419
Changes in operating assets and liabilities:      
Interest receivable 4,298 (35,215) (41,203)
Receivable for investments 47,974 93,609 (28,341)
Other assets 0 194 384
Payable for investments purchased (11,707) (15,944) (12,365)
Due to affiliates (1,884) 4,168 1,281
Management fee payable 4,439 783 7,535
Income based incentive fee payable 9,600 4,964 4,547
Capital gains incentive fee payable (5,506) (11,883) 16,312
Interest payable (5,409) 6,145 24,429
Accrued expenses and other liabilities 11,966 (2,244) 2,529
Net cash provided by (used in) operating activities 458,815 672,948 (3,828,514)
Cash flows from financing activities:      
Borrowings on debt 1,440,343 920,827 5,778,952
Repayments on debt (2,091,209) (877,152) (2,780,121)
Deferred financing costs paid (8,589) (3,789) (9,359)
Debt issuance costs paid 0 0 (3,398)
Deferred offering costs paid on issuance of common shares 0 (1,607) 0
Dividends paid in cash (437,966) (423,441) (253,776)
Proceeds from issuance of common shares, net of offering and underwriting costs 665,260 0 981,102
Redemptions paid in cash 0 (263,017) 0
Net cash provided by (used in) financing activities (432,161) (648,179) 3,713,400
Net increase (decrease) in cash and cash equivalents 26,654 24,769 (115,114)
Effect of foreign exchange rate changes on cash and cash equivalents (3,069) 3,624 0
Cash and cash equivalents, beginning of period 131,272 102,879 217,993
Cash and cash equivalents, end of period 154,857 131,272 102,879
Supplemental information and non-cash activities:      
Interest paid during the period 256,478 182,152 94,552
Distribution payable 143,052 96,218 89,715
Reinvestment of distributions during the period 20,651 52,382 38,939
Non-cash deferred financing costs activity 0 0 (64)
Non-cash debt issuance costs activity 0 0 (92)
Accrued but unpaid debt issuing costs 0 0 1,573
Excise taxes paid $ 5,245 $ 4,106 $ 131